Glycopyrrolate Injection is a fast-acting anticholinergic agent widely used in hospital and surgical settings. It works by inhibiting muscarinic receptors, effectively reducing salivary, tracheobronchial, and gastric secretions, and preventing bradycardia during anesthesia. Glycopyrrolate is also used in managing peptic ulcers, hypersalivation, and certain respiratory conditions. Administered intravenously or intramuscularly under strict medical supervision, it provides rapid and reliable action, ensuring patient safety and comfort during procedures. Its precise dosing, quick onset, and predictable effects make Glycopyrrolate Injection 0.2 mg an essential medicine in operative, critical care, and emergency applications.